The possible co-occurrence of high BRCA1 demand to repair DNA damage caused by activated transcription via ERα bound with S-protein along with dysfunction of BRCA1 sequestrated by S-protein raises concerns about increased cancer risk in ERα-sensitive cells in mRNA-LNP SARS-CoV-2 vaccine recipients. The gene discussed is BRCA1; the disease is cancer.